Polar Asset Management Partners’s Haemonetics HAE Stock Holding History

Polar Asset Management Partners’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-70,800	Closed	-$5M	–	1380
2021 Q3	$5M	Buy	+70,800	New	+$4.47M	0.05%	387
2021 Q2	–	Sell	-24,900	Closed	-$2.76M	–	1194
2021 Q1	$2.76M	Buy	+24,900	New	+$3.08M	0.03%	456
2020 Q4	–	Sell	-30,000	Closed	-$2.62M	–	836
2020 Q3	$2.62M	Sell	30,000 -160,000	-84%	-$14M	0.04%	243
2020 Q2	$17M	Buy	190,000 +145,000	+322%	+$14.6M	0.28%	92
2020 Q1	$4.49M	Buy	+45,000	New	+$4.88M	0.09%	200

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Polar Asset Management Partners's HAE Position: Q4 2021 in Review

Polar Asset Management Partners sold out of Haemonetics (HAE) in Q4 2021, closing a stake of 70,800 shares — an estimated $5M sold.

Polar Asset Management Partners first reported a position in HAE in Q1 2020 and held it in 5 quarters. The position peaked at $17M in Q2 2020. 257 funds tracked by Wall St. Rank hold HAE as of Q4 2021.

Polar Asset Management Partners reported no remaining Haemonetics position as of Q4 2021 after selling out during the quarter.
Polar Asset Management Partners sold 70,800 Haemonetics shares in Q4 2021, an estimated $5M.
Polar Asset Management Partners first reported a position in Haemonetics in Q1 2020 and held it in 5 quarters.
Polar Asset Management Partners's Haemonetics position peaked at $17M in Q2 2020.
257 funds tracked by Wall St. Rank held Haemonetics as of Q4 2021.

Based on Polar Asset Management Partners's 13F filing for Q4 2021, filed 14 Feb 2022.